Figure 1: Schematic displays of the effect of a prognostic gene expression signature (GES) on the linear predictor (Figure 1a) compared to a GES exhibiting predictive value (Figure 1b) in the setting of a two-armed trial and a dichotomous GES.
Figure 1: Schematic displays of the effect of a prognostic gene expression signature (GES) on the linear predictor (Figure 1a) compared to a GES exhibiting predictive value (Figure 1b) in the setting of a two-armed trial and a dichotomous GES.